急性缺血性卒中（acute ischemic stroke，AIS）是全球范围内导致死亡和残疾的主要原因之一，其治疗的关键在于尽早恢复脑组织的血流灌注，以最大限度地减少脑损伤和改善预后。虽然与大血管闭塞（large vessel ...

Recombinant human prourokinase is noninferior to alteplase and associated with decreased bleeding risks among patients with ...

A newly published systematic review and meta-analysis underscores the enduring benefits of endovascular thrombectomy (EVT) ...

Elezanumab (ABT-555) is under development for the treatment of acute ischemic stroke, acute traumatic cervical spinal cord injury and Cerebral infarction. It is administered as an intravenous infusion ...

Prehospital management in a mobile stroke unit vs EMS management is associated with a significantly lower level of disability at discharge.

Nerinetide is under clinical development by NoNO and currently in Phase III for Acute Ischemic Stroke. According to GlobalData, Phase III drugs for Acute Ischemic Stroke have a 13% phase transition ...

Soura, Kashmir’s largest multi-specialty tertiary care hospital, has reported a significant increase in stroke cases over the ...

JJ is a 75-year-old man who presents to the office after his wife made an appointment for him this morning for evaluation of ...

Sleep-disordered breathing improvements were not associated with functional, cognitive, or neurologic outcomes in the first ...

Navigantis plans to treat neurovascular diseases, including stroke and aneurysms, which are leading causes of death and ...

Navigantis recently announced the first successful neurovascular clinical cases performed with its Vasco interventional ...